CVKD
Cadrenal Therapeutics Inc
NASDAQ · Pharmaceuticals
$5.70
+0.36 (+6.74%)
Open$5.49
Previous Close$5.34
Day High$6.01
Day Low$5.49
52W High$21.53
52W Low$9.80
Volume—
Avg Volume222.4K
Market Cap13.33M
P/E Ratio21.42
EPS$0.67
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+197.4% upside
Current
$5.70
$5.70
Target
$16.95
$16.95
$12.65
$16.95 avg
$22.59
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.07M | 2.13M | 1.91M |
| Net Income | 662.5K | 666.1K | 461.6K |
| Profit Margin | 32.0% | 31.3% | 24.1% |
| EBITDA | 955.8K | 1.01M | 1.06M |
| Free Cash Flow | 570.9K | 515.8K | 427.8K |
| Rev Growth | +2.5% | +18.2% | +2.4% |
| Debt/Equity | 0.18 | 0.20 | 0.19 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |